Investors searching for large-cap U.S. equity exposure frequently land on two funds that sound similar but work quite differently: the iShares Core Dividend Growth ETF (DGRO) and the Vanguard Mega Cap Value ETF (MGV). Both occupy the "large value" category and appeal to income- and quality-oriented investors, but they are not direct substitutes. DGRO is a dividend-growth strategy emphasizing companies with a track record of raising payouts, while MGV is a pure mega-cap value play built around valuation factors. This comparison unpacks their structural differences, sector exposure, and relative positioning to help investors decide which better fits a diversified, long-term portfolio. I also checked this using Tickeron’s AI Screener to see how the two line up against other large-cap options.
DGRO is a passively managed fund from BlackRock that tracks the Morningstar US Dividend Growth Index. The index selects U.S. companies with a consistent history of growing dividends, screening on dividend growth and payout sustainability, then weights constituents by total dividend dollars paid. The fund holds roughly 400 stocks, with top positions including Microsoft (MSFT), Apple (AAPL), ExxonMobil (XOM), Johnson & Johnson (JNJ), AbbVie (ABBV), and JPMorgan Chase (JPM).
Sector allocation is well spread: financials lead at roughly 19–20%, followed closely by technology and healthcare (each near 17–18%), with consumer staples and industrials each around 10–12%. This balanced mix reflects the fund's emphasis on mature, cash-generating businesses rather than any single theme. With an expense ratio of 0.08% and a quarterly distribution schedule, DGRO is a low-cost core holding designed for long-term dividend compounding.
MGV is a passively managed Vanguard fund that tracks the CRSP US Mega Cap Value Index. The index selects the largest U.S. companies and weights holdings toward value characteristics, effectively concentrating on the cheapest mega-cap names. The fund holds roughly 125 stocks, a far more concentrated portfolio than DGRO. Key positions include Micron Technology (MU), JPMorgan Chase (JPM), Berkshire Hathaway Class B (BRK.B), ExxonMobil (XOM), Johnson & Johnson (JNJ), and Walmart (WMT).
Financials are the dominant sector at roughly 23–25%, followed by healthcare (17–18%) and industrials (13–16%). Technology has historically been a smaller weight but has risen recently as semiconductor names such as Micron gained prominence. MGV charges a razor-thin 0.05% expense ratio, making it one of the least expensive value ETFs available. Its deep-value, mega-cap construction gives it a different risk and return signature than a dividend-growth portfolio.
Both funds operate within the broader large-cap value complex, which has been shaped in recent market cycles by shifting interest-rate expectations, earnings resilience among mega-cap franchises, and rotation between growth and value styles. Rising bond yields have periodically pressured dividend-oriented equities while favoring financials through wider net interest margins. Meanwhile, renewed enthusiasm for semiconductor and artificial-intelligence-linked names has lifted the technology exposure inside value benchmarks — a dynamic more visible in MGV given its concentration in names like Micron.
Regulatory and macro forces also matter: bank capital requirements, energy pricing, and healthcare policy all influence the financials, energy, and healthcare heavyweights shared by both funds. The key structural contrast is that DGRO smooths these influences across a broader, quality-filtered basket, whereas MGV amplifies value-factor and mega-cap concentration effects. From what I see, these differences become especially relevant when volatility picks up.
In recent weeks and over the past several market cycles, MGV has carried a somewhat higher-volatility profile than DGRO, reflecting its fewer holdings and deeper value tilt. MGV's concentration in financials and its exposure to cyclical mega-caps such as Micron and ExxonMobil has made it more sensitive to sector rotation and earnings momentum, while DGRO's wider net and dividend-growth screen have produced steadier relative positioning.
Both funds have benefited from the broad strength in large-cap earnings, but their drivers differ. DGRO's performance has leaned on steady dividend compounders in technology, healthcare, and consumer staples, whereas MGV's returns have been more tied to value re-rating, bank profitability, and energy pricing. For investors weighing fund performance and volatility, DGRO offers a smoother path, while MGV offers deeper value exposure at a marginally lower cost and with greater concentration risk.
I often turn to Tickeron’s AI Screener when comparing ETFs like these. It lets me quickly filter on factors such as sector weights, volatility, and dividend trends, which helps confirm the structural differences I’ve outlined here and spot any emerging patterns worth watching.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
MGV moved below its 50-day moving average on November 18, 2026 date and that indicates a change from an upward trend to a downward trend. In 33 of 44 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 75%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MGV as a result. In 49 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.
The Moving Average Convergence Divergence Histogram (MACD) for MGV turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 37 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MGV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The RSI Indicator entered the oversold zone -- be on the watch for MGV's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for MGV crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.
Following a +1.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where MGV advanced for three days, in 288 of 343 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
MGV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 277 of 353 cases where MGV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows